FLGC 1 (-1.96%)
CA3397641026Drug ManufacturersDrug Manufacturers - Specialty & Generic

Flora Growth (FLGC) Competitor Comparison

We are evaluating the key criteria listed to compare Flora Growth (FLGC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - FLGC ranking 42 / 54

These are the competitors of Flora Growth in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Zoetis ZTS
25.43
2. Kamada KMDA
17.18
3. ProPhase Labs PRPH
14.71
4. Evolus EOLS
14.65
5. Kolinpharma KIP.MI
11.59
6. Supernus Pharmaceuticals SUPN
11.29
7. Regencell Bioscience Holdings RGC
8.65
8. Vifor Pharma G2AB.F
6.24
9. Perrigo PRGO
4.78
10. Ironwood Pharmaceuticals IRWD
4.78
11. Cumberland Pharmaceuticals CPIX
4.2
12. Collegium Pharmaceutical COLL
4
13. Pacira BioSciences PCRX
3.98
14. Linc LNC
3.97
15. Catalent CTLT
3.92
16. Alvotech ALVO
3.82
17. Phibro Animal Health PAHC
3.77
18. Taro Pharmaceutical Industries TARO
3.76
19. Amneal Pharmaceuticals AMRX
3.7
20. Elanco Animal Health ELAN
3.26
21. Zynerba Pharmaceuticals ZYNE
3
22. PetIQ PETQ
2.98
23. Green Thumb Industries R9U2.F
2.9
24. Procaps Group PROC
2.66
25. Journey Medical DERM
2.63
26. Amphastar Pharmaceuticals AMPH
2.63
27. Embecta EMBC
2.56
28. OptiNose OPTN
2.55
29. Eagle Pharmaceuticals EGRX
2.55
30. Societal CDMO SCTL
2.41
31. Alimera Sciences ALIM
2.39
32. Curaleaf Holdings CURLF
2.31
33. SCYNEXIS SCYX
2.19
34. Bausch Health Companies BHC
2.16
35. Cronos Group CRON
2.08
36. ANI Pharmaceuticals ANIP
2.01
37. Theratechnologies THTX
2
38. Relmada Therapeutics RLMD
1.92
39. Jupiter Wellness JUPW
1.84
40. Emergent BioSolutions EBS
1.84
41. Organogenesis Holdings ORGO
1.81
42. Flora Growth FLGC
1.79
43. Teva Pharmaceutical Industries TEVA
1.78
44. Universe Pharmaceuticals UPC
1.76
45. Ascend Wellness Holdings AAWH
1.76
46. Clever Leaves Holdings CLVR
1.75
47. Alpha Teknova TKNO
1.72
48. Biofrontera BFRI
1.68
49. Ayr Wellness 3KJB.F
1.63
50. Tilray Brands TLRY
1.63
51. Neoleukin Therapeutics NLTX
1.57
52. Solid Biosciences SLDB
1.54
53. Harrow Health HROW
1.53
54. Avadel Pharmaceuticals AVDL
1.47

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.